Skip to main content

Featured

Ukraine Strikes Russian Energy Hubs with Missiles and Drones

A n artilleryman of the 44th Separate Artillery Brigade, named after Hetman Danylo Apostol, of the Armed Forces of Ukraine, carries a cartridge as he prepares to fire a M777 Howitzer towards Russian troops. On December 25, 2025 , Ukraine launched a coordinated assault on Russian energy infrastructure, deploying Storm Shadow cruise missiles alongside long-range drones . According to the Ukrainian General Staff, the strikes hit the Novoshakhtinsk oil refinery in Russia’s Rostov region, one of southern Russia’s largest suppliers of diesel and jet fuel for the military. Multiple explosions were reported, and the facility was forced offline. In addition to the refinery, Ukraine’s Security Service (SBU) confirmed drone attacks on facilities in Temryuk and Orenburg . Fuel tanks in Temryuk caught fire, while a gas processing plant in Orenburg was shut down, further disrupting Russia’s energy output. Ukrainian officials stated that these operations are designed to undermine Russia’s milit...

article

Alzheimer’s vaccines get a boost from new drug approval

 

After decades of disappointment and controversy, the field of Alzheimer’s disease research has finally seen a breakthrough with the approval of the first drug that targets the underlying pathology of the condition. 

Aducanumab, a monoclonal antibody that clears amyloid plaques from the brain, was granted accelerated approval by the US Food and Drug Administration in June 2021, despite mixed results from clinical trials and objections from some experts. 

The drug’s approval has rekindled interest in other therapeutic approaches that aim to prevent or slow down the progression of Alzheimer’s, such as vaccines that stimulate the immune system to attack amyloid or tau, another protein that accumulates in the brains of people with the disease. 

Several vaccine candidates are currently in various stages of development and testing, and some researchers are optimistic that they could offer a more effective and convenient way to treat Alzheimer’s than infusions of antibodies.


Comments